Theravance Biopharma, Inc. Other Noncash Income (Expense)
Theravance Biopharma, Inc. (TBPH) reported Other Noncash Income (Expense) of -$68.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-11
- Theravance Biopharma, Inc. other noncash income (expense) for the quarter ending 2026-06-30 was -$26.00K, a 176.47% decline year-over-year.
- Theravance Biopharma, Inc. other noncash income (expense) for the quarter ending 2026-03-31 was -$42.00K, a 207.69% decline year-over-year.
- Theravance Biopharma, Inc. other noncash income (expense) for the quarter ending 2025-12-31 was -$6.00K.
- Theravance Biopharma, Inc. other noncash income (expense) for the quarter ending 2025-09-30 was $22.00K.
- Theravance Biopharma, Inc. other noncash income (expense) for fiscal 2025 was $89.00K.
- Theravance Biopharma, Inc. other noncash income (expense) for fiscal 2021 was -$10.00K, a 110.53% decline from fiscal 2020.
- Theravance Biopharma, Inc. other noncash income (expense) for fiscal 2020 was $95.00K.
- Theravance Biopharma, Inc. other noncash income (expense) for fiscal 2019 was -$146.00K, a 439.53% decline from fiscal 2018.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$68.00K 10-Q · filed 2026-08-11 | -$74.00K derived: sum of 3 quarters · filed 2026-08-11 | -$52.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | -$42.00K 10-Q · filed 2026-05-07 | -$48.00K derived: sum of 2 quarters · filed 2026-05-07 | -$26.00K derived: sum of 3 quarters · filed 2026-05-07 | $8.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $16.00K derived: sum of 2 quarters · filed 2026-03-23 | $50.00K derived: sum of 3 quarters · filed 2026-08-11 | $89.00K 10-K · filed 2026-03-23 | |
| 2025-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $56.00K derived: sum of 2 quarters · filed 2026-08-11 | $95.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $73.00K 10-Q · filed 2026-08-11 | |||
| 2025-03-31 | $39.00K 10-Q · filed 2026-05-07 | ||||
| 2021-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$178.00K derived: sum of 2 quarters · filed 2023-03-01 | $36.00K derived: sum of 3 quarters · filed 2023-03-01 | -$10.00K 10-K · filed 2023-03-01 | |
| 2021-09-30 | -$203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $11.00K derived: sum of 2 quarters · filed 2022-11-09 | -$35.00K 10-Q · filed 2022-11-09 | $18.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $168.00K 10-Q · filed 2022-08-08 | $221.00K derived: sum of 3 quarters · filed 2023-03-01 | $259.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | -$46.00K 10-Q · filed 2022-05-06 | $7.00K derived: sum of 2 quarters · filed 2023-03-01 | $45.00K derived: sum of 3 quarters · filed 2023-03-01 | $58.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $91.00K derived: sum of 2 quarters · filed 2023-03-01 | $104.00K derived: sum of 3 quarters · filed 2023-03-01 | $95.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $51.00K derived: sum of 2 quarters · filed 2021-11-08 | $42.00K 10-Q · filed 2021-11-08 | $44.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $4.00K 10-Q · filed 2021-08-05 | $6.00K derived: sum of 3 quarters · filed 2022-02-28 | -$89.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$9.00K 10-Q · filed 2021-05-06 | -$7.00K derived: sum of 2 quarters · filed 2022-02-28 | -$102.00K derived: sum of 3 quarters · filed 2022-02-28 | -$139.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$93.00K derived: sum of 2 quarters · filed 2022-02-28 | -$130.00K derived: sum of 3 quarters · filed 2022-02-28 | -$146.00K 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$132.00K derived: sum of 2 quarters · filed 2020-11-09 | -$148.00K 10-Q · filed 2020-11-09 | -$173.00K derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$53.00K 10-Q · filed 2020-08-10 | -$78.00K derived: sum of 3 quarters · filed 2021-02-26 | -$31.00K derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | -$16.00K 10-Q · filed 2020-05-08 | -$41.00K derived: sum of 2 quarters · filed 2021-02-26 | $6.00K derived: sum of 3 quarters · filed 2021-02-26 | -$370.00K derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $22.00K derived: sum of 2 quarters · filed 2021-02-26 | -$354.00K derived: sum of 3 quarters · filed 2021-02-26 | $43.00K 10-K · filed 2021-02-26 | |
| 2018-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$329.00K derived: sum of 2 quarters · filed 2019-11-08 | $68.00K 10-Q · filed 2019-11-08 | $55.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | -$376.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $21.00K 10-Q · filed 2019-08-05 | $8.00K derived: sum of 3 quarters · filed 2020-02-27 | $273.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $397.00K 10-Q · filed 2019-05-10 | $890.00K 10-Q · filed 2018-05-09 | $384.00K derived: sum of 2 quarters · filed 2020-02-27 | $649.00K derived: sum of 3 quarters · filed 2020-02-27 | $440.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $252.00K derived: sum of 2 quarters · filed 2020-02-27 | $43.00K derived: sum of 3 quarters · filed 2020-02-27 | -$10.00K 10-K · filed 2020-02-27 | |
| 2017-09-30 | $265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $56.00K derived: sum of 2 quarters · filed 2018-11-08 | $3.00K 10-Q · filed 2018-11-08 | -$179.00K derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | -$209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$262.00K 10-Q · filed 2018-08-02 | -$444.00K derived: sum of 3 quarters · filed 2019-02-28 | -$444.00K derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-03-31 | -$53.00K 10-Q · filed 2018-05-09 | -$235.00K derived: sum of 2 quarters · filed 2019-02-28 | -$235.00K derived: sum of 3 quarters · filed 2019-02-28 | -$235.00K derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | -$182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$182.00K derived: sum of 2 quarters · filed 2019-02-28 | -$182.00K derived: sum of 3 quarters · filed 2019-02-28 | -$182.00K 10-K · filed 2019-02-28 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | $144.00K derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | $144.00K derived: sum of 3 quarters · filed 2018-02-28 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | $144.00K derived: sum of 2 quarters · filed 2018-02-28 | |||
| 2015-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $65.00K 10-K · filed 2018-02-28 | |||
| 2015-09-30 | -$79.00K 10-Q · filed 2015-11-12 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$20.00K 10-K · filed 2016-03-11 | |||
| 2013-09-30 | -$20.00K 10-Q · filed 2014-11-12 | ||||
| 2012-12-31 | -$196.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |